Hong Kong targets biomedicine powerhouse status in debut five-year plan

Biomedicine is set to feature in Hong Kong’s first five-year plan, due to be unveiled next week, as the city’s top officials signal closer medical cooperation across the Greater Bay Area. Lending weight to those ambitions, global pharmaceutical company GSK emphasised its interest in expanding its role in the region’s biotech development on Wednesday, at the fifth Hong Kong International Biotechnology Conference and Exhibition (BIOHK). Speaking at the event, Hong Kong Secretary for Health Lo...